Search - tctmd.com

Displaying 621 - 640 of 4925

Sort: Relevancy | Date

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

Presentation TCT 2024

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Presenter: Ralph von Bardeleben

October 27, 2024

Presentation TCT 2024

TCT 546: Left Atrial Appendage Occlusion in Patients Undergoing Transcatheter Mitral Edge-to-Edge Repair (WATCH-TEER Study)

Presenter: Abdullah Al-Abcha

October 27, 2024

News Conference News EACTS 2024

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

Yael L. Maxwell

October 21, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News EACTS 2024

AI-Based CT Can Accurately Screen Patients for TMVR

Yael L. Maxwell

October 15, 2024

Presentation EACTS 2024

Streamlining Transcatheter Mitral Valve Replacement Screening

Presenter: Martin Beyer

October 10, 2024

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Caitlin E. Cox

October 03, 2024

Presentation

Mitral Annular Calcification (MAC): A Modern Approach For Diagnosis and Treatment

October 03, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

News Daily News

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

Todd Neale

September 30, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

Shelley Wood

September 01, 2024

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Shelley Wood

August 31, 2024

Presentation ESC 2024

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

Presenter: Volker Rudolph

August 31, 2024

News Opinion Editor's Corner

What’s Going to Be Hot at ESC 2024

Shelley Wood

August 23, 2024

News Daily News

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

Yael L. Maxwell

August 15, 2024

News Daily News

ACC/AHA Update Performance, Quality Measures for HF Care

Todd Neale

August 08, 2024

News Features

Valvular Heart Disease Has a Diversity Problem

Yael L. Maxwell

July 12, 2024

News Daily News

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Shelley Wood

July 09, 2024

Advertisement

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

TCT 546: Left Atrial Appendage Occlusion in Patients Undergoing Transcatheter Mitral Edge-to-Edge Repair (WATCH-TEER Study)

TAVI Explant Complications a ‘Big Issue’ as Procedure Numbers Climb

What’s Going to Be Big at TCT 2024?

AI-Based CT Can Accurately Screen Patients for TMVR

Streamlining Transcatheter Mitral Valve Replacement Screening

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

Mitral Annular Calcification (MAC): A Modern Approach For Diagnosis and Treatment

Pi-Cardia Receives FDA Market Clearance for ShortCut™

Varipulse Pulsed-Field Ablation System Safe, Effective in Pivotal Trial

TCTMD’s Top 10 Most Popular Stories for August 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation

What’s Going to Be Hot at ESC 2024

Only Small Minority of Eligible Patients Prescribed SGLT2 Inhibitors

ACC/AHA Update Performance, Quality Measures for HF Care

Valvular Heart Disease Has a Diversity Problem

Make Way, at Last, for the Third MitraClip RCT in Functional MR: RESHAPE-HF 2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content